Surrogate therapeutic endpoint for anti-ctla-4 based...

Details Surrogate therapeutic endpoint for anti-ctla-4 based... Surrogate therapeutic endpoint for anti-ctla-4 based...

C - Chemistry, Metallurgy

07

K

C07K 16/00 (2006.01) A61K 39/395 (2006.01)

Patent

CA 2527373

The present invention provides a method of treatment using human sequence antibodies against human CTLA-4. In particular, methods of treating cancer are provided.

L'invention concerne une méthode thérapeutique mettant en oeuvre des anticorps de séquences humaines anti-CTLA-4 humains. L'invention concerne en particulier des méthodes de traitement du cancer.

Affiliated with

Also associated with

Rating

Surrogate therapeutic endpoint for anti-ctla-4 based... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Surrogate therapeutic endpoint for anti-ctla-4 based..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Surrogate therapeutic endpoint for anti-ctla-4 based... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1681385